Global mRNA Cancer Vaccines and Therapeutics Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global mRNA Cancer Vaccines and Therapeutics market size was valued at US$ 204 million in 2024 and is forecast to a readjusted size of USD 663 million by 2031 with a CAGR of 18.6% during review period.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
This report is a detailed and comprehensive analysis for global mRNA Cancer Vaccines and Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts, in consumption value ($ Million), 2020-2031
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global mRNA Cancer Vaccines and Therapeutics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Cancer Vaccines and Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Cancer Vaccines and Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
mRNA Cancer Vaccines and Therapeutics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe mRNA Cancer Vaccines and Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Cancer Vaccines and Therapeutics, with revenue, gross margin, and global market share of mRNA Cancer Vaccines and Therapeutics from 2020 to 2025.
Chapter 3, the mRNA Cancer Vaccines and Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and mRNA Cancer Vaccines and Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Cancer Vaccines and Therapeutics.
Chapter 13, to describe mRNA Cancer Vaccines and Therapeutics research findings and conclusion.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
This report is a detailed and comprehensive analysis for global mRNA Cancer Vaccines and Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts, in consumption value ($ Million), 2020-2031
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global mRNA Cancer Vaccines and Therapeutics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Cancer Vaccines and Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Cancer Vaccines and Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
mRNA Cancer Vaccines and Therapeutics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Infectious Disease
- Cancer
- Others
- Moderna Therapeutics
- CureVac
- Translate Bio
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA
- Ethris
- Tiba Biotechnology
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe mRNA Cancer Vaccines and Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Cancer Vaccines and Therapeutics, with revenue, gross margin, and global market share of mRNA Cancer Vaccines and Therapeutics from 2020 to 2025.
Chapter 3, the mRNA Cancer Vaccines and Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and mRNA Cancer Vaccines and Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Cancer Vaccines and Therapeutics.
Chapter 13, to describe mRNA Cancer Vaccines and Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of mRNA Cancer Vaccines and Therapeutics by Type
1.3.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2024
1.3.3 Adeno Carcinomas
1.3.4 Mucinous Carcinomas
1.3.5 Adenosquamous Carcinomas
1.4 Global mRNA Cancer Vaccines and Therapeutics Market by Application
1.4.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Others
1.5 Global mRNA Cancer Vaccines and Therapeutics Market Size & Forecast
1.6 Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast by Region
1.6.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region, (2020-2031)
1.6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
1.6.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
1.6.6 South America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Moderna Therapeutics Recent Developments and Future Plans
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 CureVac Recent Developments and Future Plans
2.3 Translate Bio
2.3.1 Translate Bio Details
2.3.2 Translate Bio Major Business
2.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Translate Bio Recent Developments and Future Plans
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 BioNTech Recent Developments and Future Plans
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Sangamo Therapeutics Recent Developments and Future Plans
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Argos Therapeutics Recent Developments and Future Plans
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.7.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 In-Cell-Art Recent Developments and Future Plans
2.8 eTheRNA
2.8.1 eTheRNA Details
2.8.2 eTheRNA Major Business
2.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 eTheRNA Recent Developments and Future Plans
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Ethris Recent Developments and Future Plans
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Tiba Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of mRNA Cancer Vaccines and Therapeutics by Company Revenue
3.2.2 Top 3 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
3.2.3 Top 6 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
3.3 mRNA Cancer Vaccines and Therapeutics Market: Overall Company Footprint Analysis
3.3.1 mRNA Cancer Vaccines and Therapeutics Market: Region Footprint
3.3.2 mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
3.3.3 mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Market Share by Type (2020-2025)
4.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2025)
5.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2031)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
6.3.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
6.3.2 United States mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
7.3.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7.3.3 France mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7.3.5 Russia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7.3.6 Italy mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2020-2031)
8.3.2 China mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.5 India mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.7 Australia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
9.2 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
9.3 South America mRNA Cancer Vaccines and Therapeutics Market Size by Country
9.3.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
9.3.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
9.3.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
10.3.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
10.3.4 UAE mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 mRNA Cancer Vaccines and Therapeutics Market Drivers
11.2 mRNA Cancer Vaccines and Therapeutics Market Restraints
11.3 mRNA Cancer Vaccines and Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 mRNA Cancer Vaccines and Therapeutics Industry Chain
12.2 mRNA Cancer Vaccines and Therapeutics Upstream Analysis
12.3 mRNA Cancer Vaccines and Therapeutics Midstream Analysis
12.4 mRNA Cancer Vaccines and Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of mRNA Cancer Vaccines and Therapeutics by Type
1.3.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2024
1.3.3 Adeno Carcinomas
1.3.4 Mucinous Carcinomas
1.3.5 Adenosquamous Carcinomas
1.4 Global mRNA Cancer Vaccines and Therapeutics Market by Application
1.4.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Others
1.5 Global mRNA Cancer Vaccines and Therapeutics Market Size & Forecast
1.6 Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast by Region
1.6.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region, (2020-2031)
1.6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
1.6.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
1.6.6 South America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Moderna Therapeutics Recent Developments and Future Plans
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 CureVac Recent Developments and Future Plans
2.3 Translate Bio
2.3.1 Translate Bio Details
2.3.2 Translate Bio Major Business
2.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Translate Bio Recent Developments and Future Plans
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 BioNTech Recent Developments and Future Plans
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Sangamo Therapeutics Recent Developments and Future Plans
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Argos Therapeutics Recent Developments and Future Plans
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.7.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 In-Cell-Art Recent Developments and Future Plans
2.8 eTheRNA
2.8.1 eTheRNA Details
2.8.2 eTheRNA Major Business
2.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 eTheRNA Recent Developments and Future Plans
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Ethris Recent Developments and Future Plans
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Tiba Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of mRNA Cancer Vaccines and Therapeutics by Company Revenue
3.2.2 Top 3 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
3.2.3 Top 6 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
3.3 mRNA Cancer Vaccines and Therapeutics Market: Overall Company Footprint Analysis
3.3.1 mRNA Cancer Vaccines and Therapeutics Market: Region Footprint
3.3.2 mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
3.3.3 mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Market Share by Type (2020-2025)
4.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2025)
5.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2031)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
6.3.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
6.3.2 United States mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
7.3.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7.3.3 France mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7.3.5 Russia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7.3.6 Italy mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2020-2031)
8.3.2 China mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.5 India mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8.3.7 Australia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
9.2 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
9.3 South America mRNA Cancer Vaccines and Therapeutics Market Size by Country
9.3.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
9.3.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
9.3.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
10.3.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
10.3.4 UAE mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 mRNA Cancer Vaccines and Therapeutics Market Drivers
11.2 mRNA Cancer Vaccines and Therapeutics Market Restraints
11.3 mRNA Cancer Vaccines and Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 mRNA Cancer Vaccines and Therapeutics Industry Chain
12.2 mRNA Cancer Vaccines and Therapeutics Upstream Analysis
12.3 mRNA Cancer Vaccines and Therapeutics Midstream Analysis
12.4 mRNA Cancer Vaccines and Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Moderna Therapeutics Company Information, Head Office, and Major Competitors
Table 6. Moderna Therapeutics Major Business
Table 7. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 8. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Moderna Therapeutics Recent Developments and Future Plans
Table 10. CureVac Company Information, Head Office, and Major Competitors
Table 11. CureVac Major Business
Table 12. CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 13. CureVac mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. CureVac Recent Developments and Future Plans
Table 15. Translate Bio Company Information, Head Office, and Major Competitors
Table 16. Translate Bio Major Business
Table 17. Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 18. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. BioNTech Company Information, Head Office, and Major Competitors
Table 20. BioNTech Major Business
Table 21. BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 22. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. BioNTech Recent Developments and Future Plans
Table 24. Sangamo Therapeutics Company Information, Head Office, and Major Competitors
Table 25. Sangamo Therapeutics Major Business
Table 26. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 27. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Sangamo Therapeutics Recent Developments and Future Plans
Table 29. Argos Therapeutics Company Information, Head Office, and Major Competitors
Table 30. Argos Therapeutics Major Business
Table 31. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 32. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Argos Therapeutics Recent Developments and Future Plans
Table 34. In-Cell-Art Company Information, Head Office, and Major Competitors
Table 35. In-Cell-Art Major Business
Table 36. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 37. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. In-Cell-Art Recent Developments and Future Plans
Table 39. eTheRNA Company Information, Head Office, and Major Competitors
Table 40. eTheRNA Major Business
Table 41. eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 42. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. eTheRNA Recent Developments and Future Plans
Table 44. Ethris Company Information, Head Office, and Major Competitors
Table 45. Ethris Major Business
Table 46. Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 47. Ethris mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Ethris Recent Developments and Future Plans
Table 49. Tiba Biotechnology Company Information, Head Office, and Major Competitors
Table 50. Tiba Biotechnology Major Business
Table 51. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 52. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Tiba Biotechnology Recent Developments and Future Plans
Table 54. Global mRNA Cancer Vaccines and Therapeutics Revenue (USD Million) by Players (2020-2025)
Table 55. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players (2020-2025)
Table 56. Breakdown of mRNA Cancer Vaccines and Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 57. Market Position of Players in mRNA Cancer Vaccines and Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 58. Head Office of Key mRNA Cancer Vaccines and Therapeutics Players
Table 59. mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
Table 60. mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
Table 61. mRNA Cancer Vaccines and Therapeutics New Market Entrants and Barriers to Market Entry
Table 62. mRNA Cancer Vaccines and Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 63. Global mRNA Cancer Vaccines and Therapeutics Consumption Value (USD Million) by Type (2020-2025)
Table 64. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Type (2020-2025)
Table 65. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Forecast by Type (2026-2031)
Table 66. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025)
Table 67. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Forecast by Application (2026-2031)
Table 68. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 69. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 70. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 71. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 72. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 73. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 74. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 75. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 76. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 77. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 78. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 79. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 80. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 81. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 82. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 83. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 84. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
Table 85. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
Table 86. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 87. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 88. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 89. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 90. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 91. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 92. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 93. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 94. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 95. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 96. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 97. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 98. Global Key Players of mRNA Cancer Vaccines and Therapeutics Upstream (Raw Materials)
Table 99. Global mRNA Cancer Vaccines and Therapeutics Typical Customers
Table 1. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Moderna Therapeutics Company Information, Head Office, and Major Competitors
Table 6. Moderna Therapeutics Major Business
Table 7. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 8. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Moderna Therapeutics Recent Developments and Future Plans
Table 10. CureVac Company Information, Head Office, and Major Competitors
Table 11. CureVac Major Business
Table 12. CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 13. CureVac mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. CureVac Recent Developments and Future Plans
Table 15. Translate Bio Company Information, Head Office, and Major Competitors
Table 16. Translate Bio Major Business
Table 17. Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 18. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. BioNTech Company Information, Head Office, and Major Competitors
Table 20. BioNTech Major Business
Table 21. BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 22. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. BioNTech Recent Developments and Future Plans
Table 24. Sangamo Therapeutics Company Information, Head Office, and Major Competitors
Table 25. Sangamo Therapeutics Major Business
Table 26. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 27. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Sangamo Therapeutics Recent Developments and Future Plans
Table 29. Argos Therapeutics Company Information, Head Office, and Major Competitors
Table 30. Argos Therapeutics Major Business
Table 31. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 32. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Argos Therapeutics Recent Developments and Future Plans
Table 34. In-Cell-Art Company Information, Head Office, and Major Competitors
Table 35. In-Cell-Art Major Business
Table 36. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 37. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. In-Cell-Art Recent Developments and Future Plans
Table 39. eTheRNA Company Information, Head Office, and Major Competitors
Table 40. eTheRNA Major Business
Table 41. eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 42. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. eTheRNA Recent Developments and Future Plans
Table 44. Ethris Company Information, Head Office, and Major Competitors
Table 45. Ethris Major Business
Table 46. Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 47. Ethris mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Ethris Recent Developments and Future Plans
Table 49. Tiba Biotechnology Company Information, Head Office, and Major Competitors
Table 50. Tiba Biotechnology Major Business
Table 51. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 52. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Tiba Biotechnology Recent Developments and Future Plans
Table 54. Global mRNA Cancer Vaccines and Therapeutics Revenue (USD Million) by Players (2020-2025)
Table 55. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players (2020-2025)
Table 56. Breakdown of mRNA Cancer Vaccines and Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 57. Market Position of Players in mRNA Cancer Vaccines and Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 58. Head Office of Key mRNA Cancer Vaccines and Therapeutics Players
Table 59. mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
Table 60. mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
Table 61. mRNA Cancer Vaccines and Therapeutics New Market Entrants and Barriers to Market Entry
Table 62. mRNA Cancer Vaccines and Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 63. Global mRNA Cancer Vaccines and Therapeutics Consumption Value (USD Million) by Type (2020-2025)
Table 64. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Type (2020-2025)
Table 65. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Forecast by Type (2026-2031)
Table 66. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025)
Table 67. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Forecast by Application (2026-2031)
Table 68. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 69. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 70. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 71. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 72. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 73. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 74. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 75. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 76. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 77. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 78. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 79. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 80. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 81. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 82. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 83. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 84. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
Table 85. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
Table 86. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 87. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 88. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 89. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 90. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 91. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 92. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 93. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 94. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 95. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 96. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 97. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 98. Global Key Players of mRNA Cancer Vaccines and Therapeutics Upstream (Raw Materials)
Table 99. Global mRNA Cancer Vaccines and Therapeutics Typical Customers
LIST OF FIGURES
Figure 1. mRNA Cancer Vaccines and Therapeutics Picture
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2024
Figure 4. Adeno Carcinomas
Figure 5. Mucinous Carcinomas
Figure 6. Adenosquamous Carcinomas
Figure 7. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application in 2024
Figure 9. Infectious Disease Picture
Figure 10. Cancer Picture
Figure 11. Others Picture
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market mRNA Cancer Vaccines and Therapeutics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region (2020-2031)
Figure 16. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region in 2024
Figure 17. North America mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 20. South America mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players in 2024
Figure 24. mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of mRNA Cancer Vaccines and Therapeutics by Player Revenue in 2024
Figure 26. Top 3 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
Figure 27. Top 6 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
Figure 28. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Type (2020-2025)
Figure 29. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Type (2026-2031)
Figure 30. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Application (2020-2025)
Figure 31. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Application (2026-2031)
Figure 32. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 33. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 34. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 35. United States mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 42. France mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region (2020-2031)
Figure 49. China mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 52. India mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 55. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 56. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 57. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 66. mRNA Cancer Vaccines and Therapeutics Market Drivers
Figure 67. mRNA Cancer Vaccines and Therapeutics Market Restraints
Figure 68. mRNA Cancer Vaccines and Therapeutics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. mRNA Cancer Vaccines and Therapeutics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. mRNA Cancer Vaccines and Therapeutics Picture
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2024
Figure 4. Adeno Carcinomas
Figure 5. Mucinous Carcinomas
Figure 6. Adenosquamous Carcinomas
Figure 7. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application in 2024
Figure 9. Infectious Disease Picture
Figure 10. Cancer Picture
Figure 11. Others Picture
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market mRNA Cancer Vaccines and Therapeutics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region (2020-2031)
Figure 16. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region in 2024
Figure 17. North America mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 20. South America mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players in 2024
Figure 24. mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of mRNA Cancer Vaccines and Therapeutics by Player Revenue in 2024
Figure 26. Top 3 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
Figure 27. Top 6 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
Figure 28. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Type (2020-2025)
Figure 29. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Type (2026-2031)
Figure 30. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Application (2020-2025)
Figure 31. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Application (2026-2031)
Figure 32. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 33. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 34. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 35. United States mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 42. France mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region (2020-2031)
Figure 49. China mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 52. India mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 55. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 56. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 57. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE mRNA Cancer Vaccines and Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 66. mRNA Cancer Vaccines and Therapeutics Market Drivers
Figure 67. mRNA Cancer Vaccines and Therapeutics Market Restraints
Figure 68. mRNA Cancer Vaccines and Therapeutics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. mRNA Cancer Vaccines and Therapeutics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
